Mao et al.
(1 mmol) of sodium ascorbate were added to the mixture. After stir-
red for 10 min at room temperature, 1.0 mmol azidobenzene was
added and the resulting mixture was stirred for further 6 h at the
room temperature (monitored by thin-layer chromatography (TLC)).
After completion of the reaction, water was added and the mixture
was extracted with ethyl acetate (2 · 20 mL). The combined
organic extracts were washed with brine and dried over magnesium
sulphate. The solvent was evaporated in vacuum, and the residue
was purified on silica gel with ether petroleum–ethyl acetate (V:V,
1:1) and 5a was obtained. The data of all obtained compounds 5
are shown in Table 1.
N-CH2), 2.58 (s, 4H, CH2-N-CH2). Anal. Calcd for C21H24ClN5O2: C,
60.94; H, 5.844; N, 16. 92. Found: C, 60.07; H, 6.15; N,16.53.
1-(2¢-Chloro)phenyl-4-[N-[3-chloro-4-(2¢-morphol-
inothoxy)]phenyl]aminomethyl]-1H-1,2,3-
triazoles 5d
1H NMR (CDCl3, 400 MHz), d: 7.80 (s, 1H, triazolyl-H), 7.59 (d, 2H,
J = 8.7, Ar-H), 6.97 (d, 2H, J = 8.7, Ar-H), 6.81 (d, 2H, J = 8.7,
2 · Ar-H), 6.72 (d, 1H, J = 1.5, Ar-H), 6.54 (t, 2H, 2 · Ar-H), 4.42 (s,
2H, CH2), 4.29 (s, 1H, NH), 4.05 (t, 2H, O-CH2), 3.83 (s, 3H, CH3),
3.73 (t, 4H, CH2-O-CH2), 2.78 (t, 2H, N-CH2), 2.59 (s, 4H, CH2-N-
CH2). Anal. Calcd for C22H27N5O2: C, 66.47; H, 6.64; N, 18.46.
Found: C, 66.61; H, 6.47; N, 18.69.
1-Phenyl-4-[N-[4-(2¢-morpholinothoxy)]
phenyl]aminomethyl]-1H-1,2,3-triazoles 5a
1H NMR (CDCl3, 400 MHz), d: 7.87 (s, 1H, triazolyl-H), 7.70 (d, 2H,
J = 8.0, 2 · Ar-H), 7.51 (t, 2H, 2 · Ar-H), 7.43 (t, 1H, Ar-H), 6.87 (d,
J = 8.9, 2H, 2 · Ar-H), 6.66 (d, 2H, J = 8.9, 2 · Ar-H), 4.50 (s, 2H,
CH2), 4.04 (t, 2H, O-CH2), 3.73 (t, 4H, CH2-O-CH2), 2.77 (t, 2H, N-
CH2), 2.58 (t, 4H, CH2-N-CH2). Anal. Calcd for C21H25N5O2: C, 66.47;
H, 6.64; N, 18.46. Found: C, 66.61; H, 6.47; N, 18.69.
1-(4¢-Methoxy)phenyl-4-[N-[2-(2¢-morpholino-
thoxy)]phenyl]aminomethyl-1H-1,2,3-triazoles
5e
1H NMR (CDCl3, 400 MHz), d: 7.80 (s, 1H, triazolyl-H), 7.58 (d, 2H,
J = 8.7, Ar-H), 7.00 (d, 2H, J = 8.7, Ar-H), 6.88 (t, 1H, Ar-H), 6.82 (d,
1H, J = 1.5, Ar-H), 6.71 (d, 2H, 2 · Ar-H), 4.57 (s, 2H, CH2), 4.14 (t,
2H, O-CH2), 3.85 (s, 3H, CH3), 3.73 (t, 4H, CH2-O-CH2), 2.82 (t, 2H,
N-CH2), 2.59 (s, 4H, CH2-N-CH2). Anal. Calcd for C23H29N5O3: C,
65.23; H, 6.90; N, 16.54. Found: C, 65.52; H, 6.60; N, 16.78.
1-Phenyl-4-[N->[2-(2¢-morpholinothoxy>)]
phenyl]aminomethyl]-1H-1,2,3-triazoles 5b
1H NMR (CDCl3, 400 MHz), d: 7.88 (s, 1H, triazolyl-H), 7.69 (d, 2H,
J = 8.1, 2 · Ar-H), 7.49 (t, 2H, 2 · Ar-H), 7.41 (t, 1H, Ar-H), 6.88 (t,
1H, Ar-H), 6.82 (d, 1H, J = 7.7, Ar-H), 6.68 (t, 2H, 2 · Ar-H), 4.58 (s,
2H, CH2), 4.14 (t, 2H, O-CH2), 3.73 (t, 4H, CH2-O-CH2), 2.82 (s, 2H,
N-CH2), 2.58 (s, 4H, CH2-N-CH2). Anal. Calcd for C22H27N5O2:C,
66.47; H, 6.64; N, 18.46. Found: C, 66.12; H, 6.23; N, 18.91.
1-(4¢-Trifluoromethyl)phenyl-4-[N-[4-(2¢-
morpholinothoxy)]phenyl]aminomethyl]-1H-
1,2,3-triazoles 5f
1H NMR (CDCl3, 400 MHz), d: 7.94 (s, 1H, triazolyl-H), 7.85 (d, 2H,
J = 8.2, Ar-H), 7.76 (d, 2H, J = 8.1, Ar-H), 6.79 (d, 2H, J = 8.5,
2 · Ar-H), 6.64 (d, 2H, J = 8.5, 2 · Ar-H), 4.50 (s, 2H, CH2), 4.04 (t,
2H, O-CH2), 3.73 (s, 4H, CH2-O-CH2), 2.76 (t, 2H, N-CH2), 2.56 (s, 4H,
CH2-N-CH2). Anal. Calcd for C22H24F3N5O2: C, 59.02; H, 5.41; N,
15.65. Found: C, 58.91; H, 5.36; N, 15.52.
1-(4¢-Methoxy)phenyl-4-[N-[2-(2¢-morpholino-
thoxy)]phenyl]aminomethyl]-1H-1,2,3-triazoles
5c
1H NMR (CDCl3, 400 MHz), d: 7.86 (s, 1H, triazolyl-H), 7.56 (d, 1H,
J = 8.2, Ar-H), 7.56 (t, 1H, Ar-H), 7.43 (t, 2H, 2 · Ar-H), 6.79 (d, 2H,
J = 8.4, Ar-H), 6.66 (d, 2H, J = 8.2, 2 · Ar-H), 4.51 (s, 2H, CH2),
4.04 (t, 2H, O-CH2), 3.73 (d, 4H, J = 3.5, CH2-O-CH2), 2.76 (t, 2H,
1-(2¢-Nitro)phenyl-4-[N-[2-(2¢-morpholinothoxy)]
phenyl]aminomethyl]-1H-1,2,3-triazoles 5g
1H NMR (CDCl3, 400 MHz), d: 8.03 (s, 1H, triazolyl-H), 7.78 (d, 1H,
J = 7.6, Ar-H), 7.74 (t, 1H, J = 8.1, Ar-H), 6.79 (t, 1H, Ar-H), 6.60 (d,
1H, J = 7.8, 2 · Ar-H), 6.88 (t, 1H, Ar-H), 6.81 (d, 1H, J = 7.7, Ar-
H), 6.68 (t, 2H, 2 · Ar-H), 4.61 (s, 2H, CH2), 4.13 (t, 2H, O-CH2),
3.73 (s, 4H, CH2-O-CH2), 2.83 (t, 2H, N-CH2), 2.60 (s, 4H, CH2-N-
CH2). Anal. Calcd for C21H24N6O4: C, 59.42; H, 5.70; N, 19.80.
Found: C, 59.63; H, 5.44; N, 19.54.
Table 1: Data of compounds 5
Compound
X
R1
R2
R3
Yield(%)
Mp(ꢀC)
5a
5b
5c
5d
5e
5f
p-NH
o-NH
o-NH
p-NH
o-NH
p-NH
o-NH
p-NH
p-NH
p-NH
p-NH
p-NH
p-NH
H
H
H
Cl
H
H
H
Cl
Cl
H
H
H
Cl
H
H
H
NO2
H
NO2
Cl
Cl
Cl
Cl
H
H
H
H
H
H
H
H
H
H
Cl
Cl
H
H
H
H
76.4
77.3
68.6
78.5
69.7
82.6
64.9
76.6
65.7
72.5
76.8
74.9
72.4
111–112
Syrup
Syrup
137–138
Syrup
150–151
Syrup
110–111
Syrup
Syrup
88–89
Syrup
97–98
OCH3
OCH3
CF3
H
CF3
H
NO2
Cl
Cl
1-(4¢-Trifluoromethyl)phenyl-4-[N-[3-chloro-4-(2¢-
morpholinothoxy)]phenyl]aminomethyl]-1H-
1,2,3-triazoles 5h
1H NMR (CDCl3, 400 MHz), d: 7.96 (s, 1H, triazolyl-H), 7.85 (d, 2H,
J = 9.4, 2 · Ar-H), 7.77 (d, 2H, J = 9.4, 2 · Ar-H), 6.82 (d, 1H,
J = 8.7, Ar-H), 6.73 (d, 1H, J = 3.7, Ar-H), 6.54 (q, 1H, Ar-H), 6.81
(d, 1H, J = 7.7, Ar-H), 4.47 (s, 2H, CH2), 4.06 (t, 2H, O-CH2), 3.72 (t,
4H, CH2-O-CH2), 2.79 (t, 2H, N-CH2), 2.60 (s, 4H, CH2-N-CH2). Anal.
5g
5h
5i
5j
5k
5l
H
Cl
Cl
5m
NO2
696
Chem Biol Drug Des 2011; 78: 695–699